ArticleAnnals of surgical oncology2025
CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver Metastases.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores.Updates in surgery · 2026Article
- Assessment of prognostic stratification in colorectal cancer liver metastases using preoperative CT habitat imaging.Frontiers in oncology · 2026Article
- Development and independent validation of explainable radiomics-based machine learning models for prognosis in colorectal liver metastases.Frontiers in digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
purposeTo build computed tomography (CT)-based radiomics models, with independent external validation, to predict recurrence and disease-specific mortality in patients with colorectal liver metastases (CRLM) who underwent liver resection.
methods113 patients were included in this retrospective study: the internal training cohort comprised 66 patients, while the external validation cohort comprised 47. All patients underwent a CT study before surgery. Up to five visible metastases, the whole liver volume, and the surrounding free-disease parenchymal liver were separately delineated on the portal venous phase of CT. Both radiomic features and baseline clinical parameters were considered in the models' building, using different families of machine learning (ML) algorithms.
resultsThe Support Vector Machine and Naive Bayes ML classifiers provided the best predictive performance. A relevant role of second-order and higher-order texture features emerged from the largest lesion and the liver residual parenchyma. The prediction models for recurrence showed good accuracy, ranging from 70% to 78% and from 66% to 70% in the training and validation sets, respectively. Models for predicting disease-related mortality performed worse, with accuracies ranging from 67% to 73% and from 60% to 64% in the training and validation sets, respectively.
conclusionsCT-based radiomics, alone or in combination with baseline clinical data, allowed the prediction of recurrence and disease-specific mortality of patients with CRLM, with fair to good accuracy after validation in an external cohort. Further investigations with a larger patient population for training and validation are needed to corroborate our analyses.
Indexed as
Identifiers
40928578What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.